NanoHive Medical, Canary Medical to Develop Smart Spinal Cages

Canary Medical and NanoHive Medical have brokered an exclusive partnership to jointly develop next-generation smart spinal cages that integrate Canary Medical’s proprietary implantable sensing technology with NanoHive’s proprietary Hive Soft Titanium spinal implant design capabilities.

The partnership unites two organizations focused on advancing spine care through intelligent implant technology. By integrating smart sensing capabilities into spinal interbody fusion cages, the companies intend to deliver objective, actionable data that enhances visibility into patient recovery, biomechanics, and fusion progression. This approach aims to support more informed clinical decision-making and strengthen outcomes across the care continuum.

Spinal fusion outcomes remain variable, with published data suggesting that nearly half of patients report some dissatisfaction after their procedure due to persistent pain, functional limitations, and uncertainty around fusion progression. Currently, however, recovery is assessed primarily through periodic imaging and patient-reported symptoms, offering only episodic snapshots rather than continuous insight.

Smart spinal cages offer a new paradigm by embedding sensing technology directly into the implant to generate objective, longitudinal data on fusion progression, segment mobility, and patient activity, thereby enabling earlier identification of recovery deviations, more personalized rehabilitation, and data-informed intervention. Building on Canary Medical’s U.S. Food and Drug Administration (FDA)-cleared smart knee platform, the partnership with NanoHive extends validated active implant architecture into the spine to address a large market with significant unmet need.     

“Canary Medical was founded on the belief that medical devices should do more than provide structural support, they should be interconnected and collect real-time data from the patient,” Canary Medical Founding Member/CEO/Chief Medical Officer Dr. Bill Hunter said. “NanoHive has developed a portfolio of spinal implants that are a perfect fit for our technology, with the design allowing space for our smart implant while maintaining the porous structure and ideal modulus that promotes bone growth and stability. By combining our smart implant platform with NanoHive’s design expertise, we have a unique opportunity to redefine what spinal implants can deliver for surgeons and patients.”

The global spinal fusion market, driven primarily by lumbar procedures, is estimated at $6 billion to $9 billion and projected to exceed $13 billion to $16 billion over the next decade, driven by an aging population and rising degenerative spine disease rates. With more than 1 million procedures performed globally annually, the companies claim data-enabled spinal cages can establish a differentiated, premium segment within a large and established implant market, aligning with the healthcare system’s increasing emphasis on measurable outcomes and value-based care.

NanoHive Medical has built its reputation on advanced engineering, porous structures, and implant designs that support bone integration and stability. Through this collaboration, the company will accelerate its smart technology development efforts by integrating Canary Medical’s smart technology into its spinal cage platforms, creating a differentiated category of implants that support both mechanical and clinical performance.

“NanoHive’s mission is to leverage the success of our Soft Titanium platform technology to become a leader in spinal fusion personalization,” NanoHive Medical President/CEO Patrick O’Donnell stated. “Canary Medical’s leadership in implantable sensing technology makes them the ideal partner as we move into the era of intelligent spine implants. This collaboration is an important milestone in delivering to patients, surgeons, and other spinal fusion stakeholders a tool that generates meaningful, ultimately predictable, clinical data to guide better outcomes. In addition, the partnership allows us to substantially reduce development and regulatory risks and costs.”  

Joint development efforts will begin immediately, focusing on design integration, engineering validation, and defining key clinical applications.

Canary Medical is pioneering active implantable platforms and artificial intelligence (AI)-driven analytics to build a future where connected devices continuously inform treatment and lower overall healthcare costs. Its patented canturio te technology powers the world’s first FDA-approved smart knee that autonomously collects and transmits objective mobility and joint performance data from inside the body. Canary has built one of the largest real-world datasets in total joint arthroplasty, supporting more informed clinical decisions and measurable improvements in patient recovery. The company is leveraging its core sensing, power, and data architecture to expand intelligent implants across additional therapeutic categories.

NanoHive Medical LLC is a commercial-stage pioneer in 3D printed spinal interbody fusion implants and instrumentation. The company is working to be the leader in spinal fusion personalization by leveraging its Hive Soft Titanium interbody fusion lattice technology in the $3.2 billion spinal interbody fusion device market. The Hive portfolio of interbody fusion devices provides surgeons and patients biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction, and integration—features that lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive Medical is based in Woburn, Mass.